Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
AZD5991 | Excenen PharmaTech
AZD5991 (AZD-5991) | Mcl-1 inhibitor | Probechem Biochemicals
[MCL-1 Selective Inhibitors] AZD5991 (AZD-5991) [CT-A5991][CAS no ...
Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity ...
AZD5991 | Mcl-1 inhibitor | 2143061-81-6 | AdooQ®
Action Mechanism of a Mcl-1 Inhibitor AZD5991 - Network of Cancer Research
AZD5991 (an MCL-1 inhibitor) reduced Ba/F3-SPAG9-JAK2 cell viability A ...
A Phase 1 First-in-Human Study of the MCL-1 Inhibitor AZD5991 in ...
AZD5991 resistance induction, siRNA knockdown, and IP of BIM show a ...
AZD5991 treatment increases Mcl-1 protein levels. (A) MOLM-13 and THP-1 ...
ERK1/2 pathway inhibitors combine with the MCL1 inhibitor AZD5991 to ...
(PDF) Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical ...
AZD5991 Alone or with Venetoclax - Multiple Myeloma Clinical Trials
Results of Phase I study of MCL-1 inhibition with AZD5991 in R/R ...
AZD5991 induces intrinsic apoptosis in AML cells. (A) MOLM-13 and THP-1 ...
AZD5991 | 2143061-81-6 | Reference standards | Shimadzu Chemistry ...
c-Myc inhibition enhances AZD5991 antileukemic activity against AML ...
AZD5991 in combination with Venetoclax induces synergistic anti-MM ...
c-Myc inhibition synergizes with AZD5991 in inducing apoptosis in AML ...
AZD5991 | ≥99%(HPLC) | Selleck | Bcl-2 阻害剤
Activity of AZD5991 and AZD59911CHOP in vivo. (A) BH3 profile of ...
c-Myc plays an important role in AZD5991 sensitivity. (A-D) Whole cell ...
AZD5991 synergistically enhances apoptosis induced by gilteritinib and ...
Pre-clinical Formulation Development of an in situ Meglumine Salt of ...
AZD-5991 | Selective MCL-1 inhibitor | Antitumor | TargetMol
Free Ligand 1D NMR Conformational Signatures To Enhance Structure Based ...
Structural Identification and Synthesis of the Acyl Glucuronide of the ...
Co-crystal structures of MCL-1 in complex with its inhibitor. a ...
Combination of inhibitors of JNK (JNK-IN-8), MCL-1 (AZD5991), and ...
Multiscale Model Identifies Improved Schedule for Treatment of Acute ...
AZD5991: A Potent Mcl-1 Inhibitor for Hematological Malignancies and ...
Mechanisms of MCL-1 Protein Stability Induced by MCL-1 Antagonists in B ...
| Chemical structures of selective Mcl-1 inhibitors. The most prominent ...
APG-1252-M1 in combination with an Mcl-1 inhibitor synergistically ...
Identification and validation of Mcl-1 as a AKT and PI3Kβ inhibitor ...
The combination of osimertinib with an Mcl-1 inhibitor augments the ...
10058-F4 downregulates Mcl-1 via suppression of protein synthesis. (A ...
(PDF) Multiscale Model Identifies Improved Schedule for Treatment of ...
Mcl-1 and AKT/PI3Kβ inhibitor combination rapidly induces apoptosis in ...
Osteosarcoma cells are vulnerable to MAPK and MCL1 inhibition in vitro ...
BAK1 is a key mediator of Mcl-1 and PI3K/AKT inhibitor combination ...
c-Myc plays a critical role in the antileukemic activity of the Mcl-1 ...
Inhibition of Mcl-1 Synergistically Enhances the Antileukemic Activity ...
Apoptosis induced by combined ERK1/2 pathway and MCL1 inhibition ...
Anti-apoptotic MCL-1 promotes long-chain fatty acid oxidation through ...
Mcl-1 and AKT/PI3Kβ inhibitor combination activity in a panel of 44 ...
Mcl-1 inhibition overcomes intrinsic and acquired regorafenib ...
(PDF) Mcl-1 Inhibition: Managing Malignancy in Multiple Myeloma
(Ra)-7 induces on-target intrinsic apoptosis. a Apoptosis induction in ...
Mcl-1 and AKT/PI3Kβ inhibitor combination induces regression in ...
The rationale for combination therapy using MCL-1 inhibitors. Myeloid ...
Targeting MCL-1 in cancer: current status and perspectives - PMC
Mechanisms of MCL-1 protein stability induced by MCL-1 antagonists in B ...
RCSB PDB - 6FS0: INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN ...
Structure-based design of macrocyclic inhibitors of Mcl-1. a Crystal ...
JCI Insight - Multidimensional, integrative profiling identifies BCL2L1 ...
Mcl-1/CDK9 Targeting By AZD5991/AZD4573 Overcomes Intrinsic and ...
ERK1/2 pathway inhibitors prime melanoma cells for rapid apoptosis ...
Structural Identification and Synthesis of the Acyl Glucuronide of ...
Application of ReSCoSS to the macrocyle AZD5991. a ReSCoSS conformer ...
AT101 [(-)-Gossypol] Selectively Inhibits MCL1 and Sensitizes Carcinoma ...
